QM · rank #19 · 2026-09-09
EXENS
PARIS · EUR · $3.32B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +58.61% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +6.0% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $3.32B |
| Anchor (recent) Close on 2026-08-10 | $62.60 |
| Anchor (far) Close on 2025-08-08 | $39.47 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens is a Paris-listed photonics and optoelectronics company supplying mission-critical night-vision tubes, thermal cameras, and imaging sensors primarily to defense and surveillance customers across Europe and North America.
Rationale
The 58.6% trailing momentum is directly supported by fundamental delivery — 15.3% H1 2026 revenue growth, 33% adjusted EBITDA margins, guidance raised to the upper end, and named multi-year contracts (BiNOD IDIQ, ACTinBlack 5G tubes) providing the revenue visibility that validates quality-momentum co-occurrence rather than pure sentiment rotation.
Material risks
- 1Tighter U.S. export controls or ITAR restrictions on advanced image intensifier tubes could disrupt BiNOD deliveries to the U.S. Army and curtail Photonis Defense's contribution, directly breaking the contract-visibility pillar of the thesis.
- 2Defense budget retrenchment — particularly any U.S. continuing resolution or European procurement delays — could slow BiNOD IDIQ call-offs and ACTinBlack order drawdowns, compressing the revenue growth rate that sustains the momentum signal.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.